Autor: |
Lingyan Liang, Lihua Zhao, Yichen Wei, Wei Mai, Gaoxiong Duan, Jiahui Su, Xiucheng Nong, Bihan Yu, Chong Li, Xiaping Mo, Georgia Wilson, Demao Deng, Jian Kong |
Jazyk: |
angličtina |
Rok vydání: |
2020 |
Předmět: |
|
Zdroj: |
Frontiers in Aging Neuroscience, Vol 12 (2020) |
Druh dokumentu: |
article |
ISSN: |
1663-4365 |
DOI: |
10.3389/fnagi.2020.00064 |
Popis: |
BackgroundRecently, subjective cognitive decline (SCD) has been described as the earliest at-risk state of Alzheimer’s disease (AD), and drawn attention of investigators. Studies suggested that SCD-community individuals may constitute a more vulnerable population than SCD-clinic patients, therefore, to investigate the early changes of the brain may provide guidance for treatment of the disease. We sought to investigate the changes of structure and functional connectivity alternation of the hippocampus in individuals with SCD recruited from the community using structural and resting-state functional MRI (fMRI).MethodsThirty-five SCD patients and 32 healthy controls were recruited. Resting-state fMRI data and high-resolution T1-weighted images were collected. Whole-brain voxel-based morphometry was used to examine the brain structural changes. We also used the hippocampal tail and the whole hippocampus as seeds to investigate functional connectivity alternation in SCD.ResultsIndividuals with SCD showed significant gray matter volume decreases in the bilateral hippocampal tails and enlargement of the bilateral paracentral lobules. We also found that individuals with SCD showed decreased hippocampal tail resting-state functional connectivity (rsFC) with the right medial prefrontal cortex (mPFC) and the left temporoparietal junction (TPJ), and decreased whole hippocampus rsFC with the bilateral mPFC and TPJ. These brain region and FC showing significant differences also showed significantly correlation with Montreal Cognitive Assessment (MoCA) scores.ConclusionIndividuals with SCD recruited from the community is associated with structural and functional changes of the hippocampus, and these changes may serve as potential biomarkers of SCD.Clinical Trial RegistrationThe Declaration of Helsinki, and the study was registered in http://www.chictr.org.cn. The Clinical Trial Registration Number was ChiCTR-IPR-16009144. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|